London-listed drug discovery company C4X Discovery has completed a share placement, raising a total of approximately £15 million ($20 million).
The firm said the money would be used to strengthen its balance sheet as partnering and strategic collaborations progress and pipeline development continues.
C4X said the net proceeds of the placing are expected to provide the company with at least twelve months working capital.
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze